Casualty of Post-Acquisition Layoff - Recensione dipendente - Dipendente anonimo presso Curia

1,0
7 feb 2024
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

They increased our pay to what LakePharma should have been paying us...until they laid us off.

Svantaggi

Curia acquired LakePharma in 2021 and made all kinds of promises about not downsizing or laying off any staff. Of course, they can't realistically promise this and only did it so that they could keep their staff from running off to new jobs before they laid them off themselves. I've heard there have been MULTIPLE rounds of layoffs at this point. The previous CEO was obsessed with the COVID vaccine and talked about it at every townhall. The new CEO has apparently doubled down on the firing and laying off. This company does not value it's employees enough to invest in them long term. Ever since the patent for Allegra expired they have been struggling to stay relevant.

avatar
Risposta di Curia
2y
Thank you for your review. We take all feedback into consideration when planning for the future and all reviews, like yours, are critical to our ability to implement change. We appreciate you taking the time to share about your experience.

Esplora altre recensioni su Curia

5,0
25 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great team, exciting science, growth opportunities

Svantaggi

Managing growth in difficult economic conditions

4,0
21 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

- management is very easy to talk to

Svantaggi

- the pay could be more competitive

Vedi recensioni per: Utile|Valutazione|Data|Tutto